TNGNQ (TNGNQ) Stock Price & Analysis
TNGNQ (TNGNQ) rose 0.00% to USD 0 as of June 10, 2026 at 12:25 UTC, according to Nexqual real-time market data.
TNGNQ last closed at USD 0; the session ranged USD 0–0 on volume of 270,284 shares. Market capitalization is $4,024, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 12:25 UTC.
Key Statistics (as of June 10, 2026 at 12:25 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 270,284 shares |
| Market Cap | $4,024 |
| Exchange | PNK |
Technical Analysis (TNGNQ)
Nexqual's technical model rates TNGNQ "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 12:25 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (TNGNQ)
Wall Street analysts rate TNGNQ "None", per Nexqual as of June 10, 2026 at 12:25 UTC.
| Consensus Rating | None |
|---|
Earnings (TNGNQ)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2012-06-30 | USD -1.89 vs est -2.2 ▲ beat |
| 2012-03-31 | USD -1.8 vs est -2.1 ▲ beat |
| 2011-12-31 | USD -2.6 vs est -2 ▼ miss |
Source: Nexqual, June 10, 2026 at 12:25 UTC.
Financials & Fundamentals (TNGNQ)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.1 |
| Total Cash | $5.73M |
| Total Debt | $33.33M |
| Free Cash Flow | $24.78M |
Source: Nexqual, June 10, 2026 at 12:25 UTC.
Financial Health Score (TNGNQ)
Nexqual rates TNGNQ's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 12:25 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $6M cash vs $33M debt |
| Cash Flow | Weak — Operating cash flow -$19M |
| Efficiency | Mixed — No data |
Ownership (TNGNQ)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 40.25M |
| Short % of Float | +2.47% |
Source: Nexqual, June 10, 2026 at 12:25 UTC.
Leadership (TNGNQ)
TNGNQ is led by David I. Scheer (age 72), Co-Founder & Chairman of the Board, per Nexqual as of June 10, 2026 at 12:25 UTC.
| Co-Founder & Chairman of the Board | David I. Scheer (age 72) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GNLKQ | GENELINK INC | USD 0 | ▲ 0% |
| RGDXQ | RESPONSE GENETICS INC | USD 0 | ▲ 0% |
| PZRXQ | PHASERX INC | USD 0 | ▲ 0% |
| PFND | PATHFINDER CELL THERAPY INC | USD 0 | ▲ 0% |
| VIAP | VIA PHARMACEUTICALS INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 12:25 UTC. This page is informational and not investment advice.